Acholia: absence of bile, causes

Acholia is the absence or marked reduction of bile flow into the intestinal lumen. The key visual symptom is "discolored," light-gray, or clay-colored stool (acholic stool), as bile pigments, which normally form stercobilin and color stool brown, do not enter the intestines. Acholia is usually not an independent disease, but a symptom of cholestasis: impaired bile formation or its outflow through the intrahepatic/extrahepatic ducts. Dark urine (due to bilirubinuria), itchy skin, and yellowing of the sclera and skin often appear simultaneously—a typical "cholestatic" complex. [1]

It's important to distinguish acholic stool from occasional "light-colored" stools that occur due to dietary factors or after diarrhea. Persistent light-colored stools (for hours or days), especially accompanied by itchy skin, dark urine, pain/heaviness in the right upper quadrant, or weight loss, warrant an immediate evaluation of the biliary system. In young children, acholic stools are one of the main signs of biliary atresia, where the time to diagnosis determines the outcome. [2]

Acholia itself is dangerous not only aesthetically. The lack of bile in the intestines disrupts the emulsification of fats and the absorption of vitamins A, D, E, and K, leading to steatorrhea, weight loss, osteoporosis, bleeding, and weakness. If the cause is mechanical obstruction (stone, stricture, tumor), without timely decompression, biliary sepsis and liver failure are possible. [3]

The purpose of this article is to explain why acholia occurs, how to distinguish dangerous scenarios from reversible ones, which diagnostics are prescribed first and which are prescribed based on indications, and which treatment methods today actually change the prognosis – from enzyme endoscopy to targeted pharmacotherapy for certain cholestatic diseases.

Table 1. Acholia "in the palm of your hand": what it is and what are the risks

Question	Short answer	Why is it important?
What is acholia?	Absence/deficiency of bile in the intestine → acholic stool	This is a symptom of cholestasis, not a diagnosis.
Escort	Dark urine, itching, sometimes pain/fever	Indicates the level and severity of the violation
What is dangerous?	Steatorrhea, vitamin A/D/E/K deficiencies	Risk of osteoporosis, bleeding
What to do	Urgent assessment of the biliary tract (ultrasound → MRCP/EUS)	A number of reasons require emergency care [4]

Epidemiology

Acholia as a symptom is found in a wide range of diseases – from “banal” common bile duct stones to tumors of the head of the pancreas, cholangitis, primary cholestatic liver diseases, and drug reactions. In the adult population, the frequency of episodes of cholestasis varies depending on region and age; the proportion of extrahepatic causes (obstruction by a calculus/stricture/tumor) increases after 50 years. Among the symptoms of cholestasis, light-colored stool is mentioned in most manuals as one of the most sensitive everyday “beacons.” [5]

In pediatrics, acholia is particularly important as a screening indicator for biliary atresia, a rare but dangerous condition in newborns. Countries that have implemented "stool color charts" for parents have demonstrated earlier diagnosis and better surgical outcomes (the Kasai procedure is more effective in the first 6-8 weeks of life). Technological solutions (mobile apps/color recognition algorithms) complement the charts but do not replace clinical vigilance. [6]

Gallstone disease and its complications (obstruction, cholangitis), as well as tumors of the pancreatobiliary zone (head of the pancreas, cholangiocarcinoma), account for a significant proportion of the causes of acholia in adults. Intrahepatic cholestasis of pregnancy, primary biliary cholangitis, primary sclerosing cholangitis, and drug-induced hepatotoxicity often produce an undulating course with intermittent acholia. [7]

A separate group are hereditary cholestatic diseases (PFIC, etc.). They are rare, but have been increasingly diagnosed in recent years thanks to genetic panels and new treatment options (ileal bile acid transporter inhibitors). For these diseases, light-colored stools and severe itching are a common combination of symptoms. [8]

Table 2. Where to most often “encounter” acholia (landmarks)

Group/Age	Common causes of acholia	Comment
Children in the first months	Biliary atresia, neonatal cholestasis	Urgent referral to a pediatric surgeon/hepatologist is needed.
20-50 years old	Gallstones, drug-induced cholestasis, viral hepatitis	Ultrasound as a "first step"
>50 years	Strictures/tumors, PSC/PBC	MRCP/EUS/ERCP is often required
Any age	Pregnancy (VHP), autoimmune/genetic cholestasis	Profiling treatment tactics is important [9]

Reasons

Acholia occurs due to mechanical obstruction of bile outflow (extrahepatic cholestasis) or due to decreased formation/secretion of bile in hepatocytes (intrahepatic cholestasis). Extrahepatic causes: common bile duct stones, postoperative/inflammatory strictures, tumors (cholangiocarcinoma, pancreatic head cancer), compression by lymph nodes. Intrahepatic: primary biliary cholangitis (autoimmune destruction of small ducts), primary sclerosing cholangitis, drug-induced injuries, viral/alcoholic/metabolic hepatitis, pregnancy-associated cholestasis. [10]

In newborns, the primary cause of acholic acholia is biliary atresia; less common are neonatal cholestasis of other origins. Given the "race against time" (the effectiveness of surgery decreases with delay), any acholic/very light-colored stools in an infant warrant urgent evaluation (ultrasound, biochemistry, scintigraphy/MRCP—as per protocol). [11]

Drug-induced cholestasis (antibiotics such as amoxicillin-clavulanate, anabolic steroids, some contraceptives, psychotropic drugs, etc.) can cause acholia for weeks to months; drug discontinuation is the first step. In rare cases, acholia is part of hereditary syndromes of bile acid transport disorders (PFIC, BSEP deficiency, etc.). [12]

Finally, acholia can be episodic, for example, when a stone passes and the outflow is partially restored. In such cases, stool color changes, and liver biochemistry fluctuates, which helps verify the dynamics of the process.

Table 3. Causes of Acholia - A Brief Map

Level	Specific reasons	Tips for the reception
Extrahepatic	CBD stones, strictures, tumors (pancreas, cholangio)	Pain/fever, dilated ducts on ultrasound
Intrahepatic	PBC, PSC, hepatitis, drug-induced, VHP	Itching, ↑ALP/GGT, normal/undilated ducts
Children's	Biliary atresia, neonatal cholestasis	Acholia in an infant - urgent routing

Risk factors

The risk of extrahepatic obstruction is increased by gallstones, previous biliary surgery, chronic pancreatitis, and tumors of the pancreas and peripapillary area. Any episode of "yellow skin + dark urine + light-colored stool" accompanied by colicky pain is a reason to suspect a stone/obstruction. [13]

For intrahepatic cholestasis, female gender, age >40-50 years, autoimmune diseases (for PBC), inflammatory bowel diseases (for PSC), pregnancy (VHP), and the use of hepatotoxic/cholestatic drugs are significant. [14]

Family history and early onset suggest a possible genetic component (PFIC, etc.). In infants, additional "red flags" include prolonged jaundice after 2-3 weeks of age, poor weight gain, and acholic stools. [15]

Finally, metabolic factors (diabetes mellitus, obesity) and chronic alcohol abuse are indirect “amplifiers” of risk through liver damage, increasing the likelihood of cholestatic episodes with drug loads or infections.

Pathogenesis

Stool color is determined by stercobilin, which is formed from bilirubin in the intestine. In cholestasis, conjugated bilirubin does not reach the intestinal lumen, causing the stool to turn pale, and some bilirubin enters the blood and is filtered by the kidneys, resulting in dark urine. At the same time, the lack of bile acids disrupts the emulsification of fats, causing steatorrhea. [16]

In extrahepatic obstruction, the leading mechanism is increased pressure in the biliary tree and a "lock" at the level of the stone/stricture/tumor. In intrahepatic cholestasis, bile transport in hepatocytes/small ducts is impaired (autoimmune inflammation, drug-induced transporter disorders, hormonal effects of pregnancy). [17]

Pruritus associated with cholestasis is a complex phenomenon: bile acids, lysophosphatidic acid/autaptaxin, and other mediators contribute; therefore, treatment for pruritus is multi-step, ranging from bile acid sequestrants to rifampin and opioid antagonists. Acholia is only the visible tip of the iceberg of systemic disorders. [18]

Prolonged cholestasis triggers fibrosis and cirrhosis; bacterial contamination of the obstruction leads to cholangitis with the risk of sepsis. Hence the principle of "quickly restore patency where needed" while simultaneously treating the inflammation/autoimmune process.

Symptoms

The classic triad: acholic stool, dark urine, and jaundice. Frequent symptoms include itching (especially in the evening/night), fatigue, discomfort, or pain in the right hypochondrium; with stones, colicky pain and possible fever (if cholangitis occurs). With prolonged cholestasis, steatorrhea, weight loss, bleeding (vitamin K deficiency), and bone fragility (vitamin D deficiency) may occur. [19]

In young children, prolonged jaundice, acholic stools, and poor weight gain can occur. A parental "stool color chart" or color recognition apps can help shorten the time before a visit, but the decision is always up to the clinician and ultrasound/scintigraphy. [20]

In autoimmune cholestasis (PBC/PSC), itching and fatigue may be disproportionately pronounced with moderate jaundice. In tumors of the head of the pancreas, painless jaundice with achola and progressive weight loss is common. [21]

Any "waves" of acholic/dark urine accompanied by spasms in the right hypochondrium suggest stone migration. This is a scenario where time equals bile ducts: a prolonged blockage is fraught with cholangitis.

Table 4. Symptom → probable group of causes → first action

Symptom/combination	Possible causes	First examination
Acholia + colic + fever	Stone/cholangitis	Urgent: ultrasound, tests, then ERCP as indicated
Acholia + painless jaundice + weight loss	Tumor of the pancreatobiliary zone	Ultrasound → MRCP/EUS/CT, oncologic route
Acholia + severe itching, without colic	Intrahepatic cholestasis (PBC/PSC/drug-induced)	Biochemistry, autoantibodies, ultrasound; MRCP in case of suspected PSC
Newborn with acholia	Biliary atresia, etc.	Urgently see a pediatric surgeon/hepatologist, ultrasound/HIDA [22]

Forms and stages

In fact, a distinction is made between intrahepatic and extrahepatic acholia based on the level of impairment. Based on the course of the disorder, there is an acute episode (stone obstruction, acute drug-induced cholestasis) and a chronic/recurrent condition (PBC/PSC, strictures, tumors). Each form dictates its own diagnostic approach and timing of intervention. [23]

The extrahepatic variant is often "loud": pain, fever, rapid darkening of urine, achola; the intrahepatic variant is often "quiet," with predominantly itching and fatigue. In newborns, each day of delay changes the prognosis for surgical treatment of biliary atresia. [24]

The degree of acholia (complete/partial) can fluctuate due to stone migration or the "valvular" effect of stricture. In practice, this explains the fluctuations in symptoms and laboratory parameters.

In tumors and primary sclerosis, the process progresses over months to years, and acholia becomes permanent without restoration of outflow - here the key question is: how and when to ensure drainage and, in parallel, treat the primary disease. [25]

Complications and consequences

Without bile, the intestines poorly absorb fats and fat-soluble vitamins. The result is steatorrhea, weight loss, and vitamin A/D/E/K deficiencies (night blindness, osteopenia/fractures, neuromuscular disorders, and coagulopathy). Patients with chronic cholestasis experience increased rates of osteoporosis and pruritus, which significantly reduces quality of life. [26]

In case of mechanical obstruction there is a risk of ascending cholangitis (fever, pain, jaundice), liver abscesses and sepsis; emergency decompression is required (usually ERCP with stenting/sphincterotomy). [27]

Long-term cholestasis leads to fibrosis, biliary cirrhosis, and portal hypertension. Some patients with PBC/PSC develop liver complications requiring transplantation; early therapy (ursodeoxycholic acid, etc.) reduces these risks. [28]

In pediatrics, delayed diagnosis of biliary atresia worsens the results of the Kasai procedure and increases the likelihood of transplantation at an early age. Stool color screening reduces the time to referral. [29]

Diagnostics

Step 1: Confirm cholestasis with laboratory tests. We look for a "cholestatic" profile: elevated alkaline phosphatase and gamma-glutamyl transferase, increased direct (conjugated) bilirubin, and bilirubinuria in the urine. We evaluate the INR/prothrombin time (vitamin K deficiency), lipid profile, and fat-soluble vitamins in chronic cases. [30]

Step 2 - First-line imaging. Abdominal ultrasound is the basic starting point: it's readily available and quickly reveals dilated extrahepatic ducts, gallstones/CBD, pancreatic duct dilation, and signs of tumor block. If clinical symptoms are significant and the ultrasound is clear, further treatment options are discussed. [31]

Step 3: Clarifying imaging. MRCP provides a noninvasive image of the biliary tree. Endoscopic ultrasound (EUS) is superior to MRCP in sensitivity for small stones/distal strictures and allows for immediate targeted biopsy/fine-needle aspiration. The choice between MRCP and EUS is based on local availability and clinical objectives. [32]

Step 4: Diagnostic and therapeutic ERCP. It is used as a decompression tool (stone extraction, sphincterotomy, stenting), as well as for collecting material in strictures. In recent years, the synergy of EUS and ERCP has been emphasized: EUS for detection/biopsy, ERCP for therapy. In newborns, if atresia is suspected, radionuclide cholescintigraphy (HIDA) and intraoperative techniques are also used. [33]

Table 5. “Quick algorithm” for acholia in adults

Step	What are we doing?	For what
1	Laboratory: ALP, GGT, bilirubin (direct), INR	Confirm cholestasis and assess severity
2	Ultrasound	There are/there are no duct dilations, stones, “suspicious” signs
3a	MRCP or EUS	Clarify the level/cause, biopsy if necessary
3b	ERCP (as indicated)	Decompression/stone extraction/stenting
4	Etiotropic search (autoantibodies, drugs, PSC/PBC)	Determine long-term tactics [34]

Differential diagnosis

Extrahepatic versus intrahepatic block: ductal dilation on ultrasound suggests extrahepatic obstruction; in intrahepatic cholestasis, the ducts are usually normal in size, and pruritus and ↑ALP/GGT are the predominant symptoms. In painless, progressive jaundice with acholic acid, consider a tumor. [35]

We differentiate acholia from "false" light-colored stools during rapid transit/after diarrhea—as a rule, such episodes are short-lived and not accompanied by dark urine. Light-colored stools in newborns are differentiated primarily from prolonged physiological jaundice and infections; any questionable color is a reason to act, not observe. [36]

Drug-induced cholestasis (collecting a detailed drug history) and pregnancy-associated cholestasis are considered separately. In PBC/PSC, autoantibodies, MRCP patterns, and associated intracranial cholestasis are helpful. If a stricture of unknown etiology is suspected, a combination of EUS biopsy and ERCP brushing is preferred. [37]

Finally, acholia combined with fever and pain is Charcot's syndrome (pain + jaundice + fever) and the "red flag" of ascending cholangitis, where time to decompression is directly related to prognosis.

Table 6. "Is it an obstruction or not?" - a simple matrix

Sign	Extrahepatic cholestasis	Intrahepatic cholestasis
Ultrasound of the ducts	Expanded	Usually normal
Pain/fever	Often (especially with stones)	Usually no
Itching	Maybe, but not dominant.	Often expressed
Tactics	ERCP/stent/surgery	Etiotropic pharmacotherapy, observation [38]

Treatment

1) Urgent decompression of extrahepatic obstruction. For a stone/stricture/tumor block in the distal section - ERCP with sphincterotomy, stone extraction, and/or stenting. For tumors - temporary/covered stents, then oncotactic surgery. EUS helps identify small stones and perform targeted biopsy. For cholangitis, antibiotics are prescribed as indicated and always in conjunction with drainage. [39]

2) Etiotropic therapy of intrahepatic cholestasis.

• Primary biliary cholangitis (PBC): first-line therapy is ursodeoxycholic acid (UDCA). In case of incomplete response, obeticholic acid (second-line therapy; limits pruritus and has a safety profile that requires monitoring) and/or fibrates (bezafibrate/fenofibrate - off-label, but with evidence of biochemical improvement). Newer options are being developed (seladelpar, etc.), but are available within the scope of indications/registrations. [40]
• Primary sclerosing cholangitis (PSC): endoscopic dilation of dominant strictures, IVC control; UDCA does not routinely improve survival but can be used in low/moderate doses individually.

• Cholestasis of pregnancy: UDCA as the drug of choice; maternal/fetal monitoring according to specialized recommendations. [41]

3) Treatment of cholestatic pruritus is stepwise. First-line treatment is cholestyramine (a bile acid sequestrant). If the effect is insufficient, rifampin, opioid antagonists (naltrexone), or selective SSRIs (sertraline) are considered as adjuvants. For refractory pruritus, phototherapy/plasmapheresis/MES are being discussed. Local guidelines from 2024 describe a stepwise, adjunctive approach, where drugs are combined. [42]

4) New options for hereditary/severe cholestasis. Ileal bile acid transporter (IBAT) inhibitors (maralixibat, odevixibat) are targeted drugs that reduce bile acid reabsorption and pruritus in patients with Alagille syndrome and PFIC; approved by regulators for the treatment of cholestatic pruritus in these groups (age restrictions depend on the drug/registration version). [43]

5) Correction of the consequences of cholestasis. For prolonged acholia: fat-soluble vitamins A/D/E/K, calcium/vitamin D, nutritional support, and standard osteoporosis treatment. For vitamin K deficiency: parenteral replacement and INR correction. Nutritional strategy for steatorrhea: split meals, fat control as tolerated; enzymes do not replace bile, but are helpful if there is concomitant pancreatic insufficiency.

6) Surgery/oncology. For tumors - resection/neoadjuvant or palliative tactics based on a multidisciplinary decision; stenting is often used as a "bridge" to surgery or for palliation. For biliary atresia - Kasai operation in the optimal time frame. [44]

More information:

• Medicines for the treatment and restoration of the liver
• How is biliary dyskinesia treated?
• Physiotherapy for dyskinesia of the gallbladder and biliary tract
• Folk remedies for liver treatment

Table 7. “What is prescribed and when” - a brief overview of therapy

Situation	First line	Second/new options	Comments
Stone/stricture/tumor distally	ERCP: extraction/stent	EUS-assisted biopsy/therapy	Antibiotic - for cholangitis
PBC	UDHC	Obeticholic acid; fibrates (off-label)	Monitoring of pruritus/lipids/liver function tests. [45]
PSH	Endoscopic therapy of dominant strictures	Clinical trials	IVK control
Hereditary cholestasis/ALGS, PFIC	Symptomatic + vitamins	IBAT inhibitors (maralixibat/odevixibat)	Reduces itching, reduces bile acids. [46]

Prevention

Prevention of extrahepatic causes of acholia includes timely treatment of cholelithiasis and metabolic risk factors, careful use of medications that can cause cholestasis (discuss alternatives, monitor liver function tests during long-term use). For individuals with IVK, regular screening for primary cholangitis (PSC) is recommended; for women, information about the signs of cholestasis of pregnancy is recommended.

Prevention of complications of prolonged cholestasis includes early replenishment of vitamins A/D/E/K, nutritional support, osteoporosis prevention, and hepatitis vaccination when indicated. It is helpful for parents of newborns to explain the "color" markers of stool and the importance of early treatment if stool becomes discolored. [47]

Forecast

In cases of reversible obstruction, restoration of bile flow (ERCP/surgery) rapidly normalizes stool color and reduces the risk of infectious/metabolic complications; long-term prognosis is determined by the cause (stone vs. stricture vs. tumor) and the speed of intervention. [48]

In intrahepatic cholestasis, the prognosis depends on the underlying disease and response to therapy: in PBC, UDCA reduces the risk of progression, while second-line therapy (obeticholic acid, fibrates) improves biochemistry in incomplete responders; in hereditary forms, the development of IBAT inhibitors has made it possible to control pruritus and some of the metabolic consequences. Early diagnosis and a personalized treatment plan are key. [49]

Table 8. Red flags: when to go to the hospital urgently

Sign	Possible cause	Action
Acholia + fever + pain in the right hypochondrium	Ascending cholangitis	Emergency decompression (ERCP), antibiotic
Acholia + painless jaundice + weight loss	Tumor of the pancreatobiliary zone	Emergency imaging (EUS/MRCP/CT), oncologic route
Newborn with acholia	Biliary atresia	Urgently see a pediatric surgeon/hepatologist
Cholestasis + severe itching, insomnia	Severe cholestasis	Stepwise antipruritic therapy [50]

FAQ

• The stool became light-colored once - is this acholia?

A single light-colored stool does not equal acholica. The persistence of the symptom and its association with dark urine, jaundice, or itching are important. If it recurs, get tested and have an ultrasound. [51]

• Why does urine darken when stool is lighter?

Conjugated bilirubin does not enter the intestines (the stool turns pale), but enters the blood and is excreted in the urine (it darkens). This is typical of cholestasis. [52]

• What is more accurate - MRCP or endoscopic ultrasound?

Both techniques are highly informative; EUS is superior to MRCP for small stones and distal strictures and allows for immediate biopsy, while ERCP allows for the treatment of obstruction. The choice depends on the clinical objective and availability. [53]

• Is itching due to cholestasis treated only with "powders"?

No. The first line is cholestyramine, but there are steps: rifampin, naltrexone, sertraline; for hereditary forms, IBAT inhibitors are available (as indicated). Selection is based on a protocol and under the supervision of a physician. [54]

• Should everyone take antibiotics at once?

No. Antibiotics are indicated for signs of infection (cholangitis, pneumonia, etc.). In case of obstruction, the key is decompression of the bile ducts, not “antibiotic prophylaxis.” [55]